Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MaGil IRB was an AAHRPP-accredited institutional review board providing central and local IRB review services for clinical research. The company was acquired by Chesapeake IRB in 2017, which provided Chesapeake with additional AAHRPP-accredited review capacity and expanded the organization's presence among CROs, pharmaceutical companies, and biotech companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MaGil IRB.